Drug intelligence / Profile preview

De-Stress & Snooze Gummies

Development stage: Preclinical
Lead developer: Herbolab
Administration: Oral

Overview

De-Stress & Snooze Gummies is a nutraceutical product developed by Herbolab India Pvt. Ltd. It is designed to manage sleep disorders and associated symptoms, aiming to improve overall quality of life. The product is intended to enhance sleep quality, which in turn contributes significantly to cognitive function, including increased alertness, focus, productivity, and memory consolidation.

Brand names: De-Stress & Snooze Gummies
Other names: De-Stress & Snooze Gummiesthree60 De-Stress & Snooze Drops

Targets

GABA-B (Gamma-aminobutyric acid receptor type B)MTNR1A (MT1)

Beyond the preview

Go deeper on De-Stress & Snooze Gummies.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on De-Stress & Snooze Gummies.

Explore the full profile